Insulin Lispro (LP) improves postprandial glucose (PPG) without increased immunogenicity or hypoglycemia in gestational diabetic women (GDM). - Jovanovic,L.; Ilic,S.S.; Gutierrez,M.; Bastyri,E.J. (Diabetes, 1998)